{"meta":{"query_hash":"93697f358479","filters":{"venue":"Drugs and Drug Candidates"},"cohort_total":6,"direct_labels_cover":0,"predictions_cover":6,"exported":6,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/93697f358479","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drugs+and+Drug+Candidates"},"results":[{"id":"W4311111624","doi":"10.3390/ddc1010003","title":"Failed Repurposing of Lysosomotropic Drugs for COVID-19 Treatment or Prevention","year":2022,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Phospholipidosis; Pharmacology; Repurposing; Drug repositioning; Hydroxychloroquine; Drug; Endocytosis; Microvesicles; Medicine; Coronavirus disease 2019 (COVID-19); Chemistry; Biology; Disease; Cell; Pathology; Biochemistry","score_opus":0.043191892989226696,"score_gpt":0.41197590143503965,"score_spread":0.36878400844581294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311111624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3498617,0.6128423,0.0072216108,0.0059514744,0.001162963,0.0014836964,0.0007489076,0.0002733985,0.020453947],"genre_scores_gemma":[0.76513267,0.2110678,0.010177609,0.0044900747,0.0007753742,0.00056315656,0.0012483051,0.00007977773,0.0064651803],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99929726,0.00028451526,0.00012620968,0.000070222486,0.0001358273,0.00008605939],"domain_scores_gemma":[0.9990663,0.00037541607,0.00016934922,0.00008281948,0.00019749653,0.00010871289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025152734,0.00042160565,0.0014197904,0.0006721129,0.00037707886,0.00094153074,0.0005919343,0.0010093407,0.0025047688],"category_scores_gemma":[0.001825168,0.00013265987,0.00075711904,0.00036986775,0.0005984266,0.00070291193,0.0004738814,0.0012533559,0.000911666],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006721083,0.0025177489,0.005314322,0.0067848456,0.0006416314,0.0029893008,0.0004465854,0.0007714237,0.1913865,0.007892334,0.006196678,0.76833755],"study_design_scores_gemma":[0.003583578,0.08079963,0.02147571,0.0035145637,0.001745807,0.012769894,0.00077647826,0.0016042197,0.39595127,0.005531326,0.47211075,0.00013675835],"about_ca_topic_score_codex":0.00035747126,"about_ca_topic_score_gemma":0.0006182657,"teacher_disagreement_score":0.0025152734,"about_ca_system_score_codex":0.00059589447,"about_ca_system_score_gemma":0.00072506344,"threshold_uncertainty_score":0.013302207},"labels":[],"label_agreement":null},{"id":"W4353060534","doi":"10.3390/ddc2010012","title":"Optimizing Protein Production in Therapeutic Phages against a Bacterial Pathogen, Mycobacterium abscessus","year":2023,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"Bacteriophages and microbial interactions","field":"Environmental Science","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Biology; Translation (biology); Gene; Genetics; Codon usage bias; Bacteriophage; Start codon; Stop codon; Phage therapy; Genome; Computational biology; Messenger RNA; Escherichia coli","score_opus":0.007070976741720812,"score_gpt":0.22562097371345033,"score_spread":0.21854999697172953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353060534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97426116,0.000984853,0.022113416,0.00012005199,0.000026908534,0.00017037983,0.00013797397,0.000104609404,0.002080702],"genre_scores_gemma":[0.9304361,0.0013409999,0.06548957,0.00006197483,0.000013311283,0.00018076663,0.000258482,0.00009902757,0.0021198809],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958843,0.00010748323,0.000048274364,0.000062668354,0.00013510337,0.000058008296],"domain_scores_gemma":[0.99972564,0.000096679614,0.00007720322,0.000024997904,0.00004184804,0.00003365867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060023053,0.00046955445,0.00041812973,0.0003099003,0.00036024713,0.00053654355,0.00017746673,0.00036092708,0.00043618365],"category_scores_gemma":[0.0006284955,0.00029826455,0.00034657115,0.00034725873,0.0003505978,0.00027811475,0.00026087946,0.00044691373,0.00029522102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007233078,0.000049419526,0.000343849,0.000069733724,0.0000034106724,0.00004223752,0.000037725513,0.0013255519,0.9953845,0.00024987495,0.00002858882,0.0023926846],"study_design_scores_gemma":[0.000010712213,0.000322022,0.00064212596,0.0000075400962,0.000011700926,0.00006638617,0.000027077369,0.0016561223,0.9960939,0.00009374834,0.0010623707,0.000006252575],"about_ca_topic_score_codex":0.0003192578,"about_ca_topic_score_gemma":0.00058148504,"teacher_disagreement_score":0.00060023053,"about_ca_system_score_codex":0.00046284197,"about_ca_system_score_gemma":0.00045896607,"threshold_uncertainty_score":0.0033581853},"labels":[],"label_agreement":null},{"id":"W4366772115","doi":"10.3390/ddc2020015","title":"Design, Synthesis and In Vitro Studies of 3-Amidocoumarins as Novel Antibiofilm Agents","year":2023,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"Bacterial biofilms and quorum sensing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Banaras Hindu University; Council for Scientific and Industrial Research, South Africa; Science and Engineering Research Board; Canadian Institute of Steel Construction","keywords":"Biofilm; Pseudomonas aeruginosa; Quorum sensing; Docking (animal); Chemistry; Microbiology; Antibiotics; In vitro; Context (archaeology); Antibiotic resistance; Bacteria; Biology; Biochemistry; Medicine","score_opus":0.01985490917465887,"score_gpt":0.2724799531335821,"score_spread":0.2526250439589232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366772115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746114,0.012450575,0.007466702,0.00018150038,0.000057153746,0.00038657006,0.0011488025,0.00008491821,0.0036124107],"genre_scores_gemma":[0.97429276,0.00960957,0.011644326,0.000118079115,0.000023990278,0.00024644652,0.0011765214,0.000019156401,0.0028691653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999037,0.00002300947,0.000012286051,0.000018138135,0.000020645159,0.000022223245],"domain_scores_gemma":[0.99991477,0.0000132762525,0.000023285933,0.000007755425,0.000019759009,0.000021219763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023621148,0.00043622396,0.00046341657,0.00026704682,0.0001673871,0.000246499,0.0003671502,0.00029067116,0.00093163643],"category_scores_gemma":[0.00018679626,0.00020579461,0.00037007724,0.00031509637,0.00013521705,0.00024089147,0.0002078829,0.00039264973,0.0003875703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034502934,0.0002847224,0.00016517125,0.00042330238,0.000027747943,0.0003004567,0.000053736185,0.004184236,0.9865274,0.00032085463,0.00015709686,0.0072102672],"study_design_scores_gemma":[0.0001823467,0.0046310215,0.0015558433,0.00004534179,0.00006639499,0.00033408988,0.000038453232,0.0026790786,0.97860795,0.00011544373,0.011711508,0.000032500593],"about_ca_topic_score_codex":0.00047797276,"about_ca_topic_score_gemma":0.0006528968,"teacher_disagreement_score":0.00093163643,"about_ca_system_score_codex":0.00025531053,"about_ca_system_score_gemma":0.00020262825,"threshold_uncertainty_score":0.0031166673},"labels":[],"label_agreement":null},{"id":"W4383370009","doi":"10.3390/ddc2030028","title":"Drugs of the Kallikrein–Kinin System: An Overview","year":2023,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Medical Research Council; Canadian Institutes of Health Research; Medical Research Council Canada","keywords":"Kinin; Kallikrein; Kininogen; Bradykinin; Proteases; Medicine; Prekallikrein; Pharmacology; Angioedema; Receptor; Immunology; Biology; Internal medicine; Biochemistry","score_opus":0.02060281302863263,"score_gpt":0.2828391711462861,"score_spread":0.26223635811765345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383370009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066462083,0.99263716,0.00064590113,0.0009960746,0.00068129896,0.0000119810875,0.000035913785,0.000028013166,0.004299053],"genre_scores_gemma":[0.003128813,0.9911151,0.0009847858,0.0009200106,0.0011514642,0.000029221068,0.00007570158,0.000006540778,0.0025884137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984384,0.000032789845,0.000021755764,0.000027397413,0.000053843003,0.000020244788],"domain_scores_gemma":[0.9997445,0.00011825351,0.00003086331,0.000012524059,0.000059272046,0.000034635057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003506739,0.0008044568,0.000701747,0.002142563,0.000270967,0.0008815163,0.00047391938,0.0011742573,0.0034508023],"category_scores_gemma":[0.0004761513,0.00020472815,0.00037696873,0.001267926,0.00039162883,0.0014938044,0.0004956505,0.0019722108,0.0021111087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015271571,0.00032206412,0.0005606176,0.006364946,0.000068304755,0.00059717224,0.00010775946,0.0004410297,0.005609556,0.010191336,0.059143618,0.9164409],"study_design_scores_gemma":[0.000013702245,0.00031417247,0.0008565273,0.00080055936,0.00004247457,0.0026623073,0.000046853387,0.00016381723,0.00083602936,0.0022302698,0.9920151,0.000018055014],"about_ca_topic_score_codex":0.00061284367,"about_ca_topic_score_gemma":0.0010508797,"teacher_disagreement_score":0.0034508023,"about_ca_system_score_codex":0.00045023576,"about_ca_system_score_gemma":0.0006300984,"threshold_uncertainty_score":0.011544108},"labels":[],"label_agreement":null},{"id":"W4392100829","doi":"10.3390/ddc3010012","title":"Correction: Marceau, F. Drugs of the Kallikrein–Kinin System: An Overview. Drugs Drug Candidates 2023, 2, 538–553","year":2024,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Drug; Pharmacology; Medicine; Internal medicine","score_opus":0.010799971586044134,"score_gpt":0.26704560447119874,"score_spread":0.2562456328851546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392100829","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007312898,0.0021234106,0.0002057551,0.03972375,0.95643246,0.00001502513,0.00033101838,0.00012653992,0.00096887077],"genre_scores_gemma":[0.007183613,0.012825639,0.0014835028,0.095378615,0.8006773,0.00014181591,0.00096402736,0.00051204424,0.08083338],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99581784,0.0007044764,0.00065514894,0.00065393414,0.0016962279,0.00047234012],"domain_scores_gemma":[0.9751338,0.0060664522,0.0015399902,0.0012389974,0.014401133,0.0016196355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004480287,0.0026245757,0.0023674187,0.004493369,0.0022559403,0.00419472,0.003246315,0.008151432,0.029049082],"category_scores_gemma":[0.05381688,0.0010783477,0.0022687973,0.0019040286,0.0027569,0.0023549576,0.0017308367,0.015945716,0.022588778],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021933436,0.0000037783884,0.000031069903,0.00011379151,0.000011493028,0.00020488333,0.000016605767,0.000020291709,0.000027141245,0.00029638901,0.9959996,0.0032529794],"study_design_scores_gemma":[0.000046261754,0.000019932126,0.0005231446,0.00035029158,0.000036663692,0.0009730967,0.000042756863,0.00013777571,0.00018710585,0.0005591809,0.99709606,0.00002766027],"about_ca_topic_score_codex":0.014065592,"about_ca_topic_score_gemma":0.012365742,"teacher_disagreement_score":0.029049082,"about_ca_system_score_codex":0.004495058,"about_ca_system_score_gemma":0.005601892,"threshold_uncertainty_score":0.09717882},"labels":[],"label_agreement":null},{"id":"W4415680647","doi":"10.3390/ddc4040047","title":"Discovery and Characterization of 7,8-Dihydropyrido[4,3-d]pyrimidines as SARS-CoV-2 Entry Inhibitors","year":2025,"lang":"en","type":"article","venue":"Drugs and Drug Candidates","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"University of Illinois at Urbana-Champaign; University of Illinois at Chicago; University of Minnesota","keywords":"In vivo; In vitro; Docking (animal); Drug discovery; Virtual screening; Potency; Plasma protein binding; Binding site","score_opus":0.004188718560957869,"score_gpt":0.25377275115762205,"score_spread":0.24958403259666417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415680647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96495396,0.011508897,0.014364558,0.00021506824,0.000038025424,0.00064130523,0.0024611966,0.00023562668,0.00558133],"genre_scores_gemma":[0.97406036,0.0060636676,0.012559108,0.00016855837,0.000026923237,0.00014281482,0.0042262613,0.00003383094,0.0027184533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998441,0.000028109202,0.000011870446,0.00002513359,0.00005511918,0.00003566532],"domain_scores_gemma":[0.99986744,0.000017236389,0.00002946017,0.000013718162,0.000040503295,0.000031598793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026513246,0.0005169639,0.00064845977,0.00039075097,0.000166433,0.00043900477,0.0004774969,0.00033232378,0.0017815365],"category_scores_gemma":[0.0002464656,0.00014672059,0.00029285194,0.00032876755,0.00017663631,0.00022325346,0.0002327008,0.00044132676,0.00068392296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028284537,0.00035513862,0.0011842346,0.00029180493,0.00003932869,0.00034165985,0.00005252401,0.0033001706,0.9735617,0.0003979678,0.00037872998,0.019813782],"study_design_scores_gemma":[0.00036238358,0.009054563,0.007850035,0.00006235466,0.00012014522,0.0015751901,0.00007049642,0.005774147,0.96037304,0.00017716647,0.014533906,0.00004665265],"about_ca_topic_score_codex":0.0009444264,"about_ca_topic_score_gemma":0.0020892862,"teacher_disagreement_score":0.0017815365,"about_ca_system_score_codex":0.0003447023,"about_ca_system_score_gemma":0.0005331648,"threshold_uncertainty_score":0.005959809},"labels":[],"label_agreement":null}]}